Sponsors

Early diagnosis of RA

The Binding SiteÆs new, highly specific and sensitive secondgeneration anti-CCP2 enzyme-linked immunosorbent assay (ELISA) kit is the latest addition to the companyÆs comprehensive range of autoimmune BINDAZYME assays.

The kit is intended as an aid in the early diagnosis of rheumatoid arthritis, measuring specific IgG autoantibodies against secondgeneration cyclic citrullinated peptides (CCP2) in human serum.

In common with all BINDAZYME assays, the new anti-CCP2 kit is automation friendly and easy to use. Its single-well ‘break apart’ format makes it cost effective and suitable for various levels of workload.

www.bindingsite.co.uk

Latest Issues

LabMedUK26

The Eastside Rooms conference centre, Birmingham
8-10 June, 2026

London Biotechnology Show

Excel, London
9-10 June, 2026

Weqas Annual Laboratory Conference 2026

St Andrew’s Stadium, Birmingham
11th June 2026

European Human Genetics Conference

Svenska Mässan, Gothenburg, Sweden
13-16 June, 2026